Drug class

Proton Pump Inhibitors

Proton pump inhibitors are a therapeutic class of antisecretory medications that produce potent and prolonged suppression of gastric acid production. Read more about Proton Pump Inhibitors

306 drugs in this class 139 manufacturers

Advertisement

Drugs in Proton Pump Inhibitors

Showing 10–18 of 306 drugs

PANTOPRAZOLE SODIUM

PEPTIC ULCER AGENTS · ZOLLINGER-ELLISON SYNDROME ·+4
Major Pharamceuticals

LANSOPRAZOLE

PEPTIC ULCER AGENTS · ZOLLINGER-ELLISON SYNDROME ·+13
DR.REDDY'S LAB

LANSOPRAZOLE

PEPTIC ULCER AGENTS · ZOLLINGER-ELLISON SYNDROME ·+13
AHP

LANSOPRAZOLE

PEPTIC ULCER AGENTS · ZOLLINGER-ELLISON SYNDROME ·+13
TEVA USA

OMEPRAZOLE

PEPTIC ULCER AGENTS · ZOLLINGER-ELLISON SYNDROME ·+10
SANDOZ
Filter & compare in the drug finder → Opens the drug finder with Proton Pump Inhibitors preselected. Add indication or manufacturer filters there.

About Proton Pump Inhibitors.

Proton pump inhibitors are a therapeutic class of antisecretory medications that produce potent and prolonged suppression of gastric acid production.

They function by covalently binding to and irreversibly inhibiting the gastric hydrogen-potassium ATPase enzyme system, commonly referred to as the proton pump, on the secretory surface of stomach parietal cells to block the final step of acid secretion.

Agents in this class are widely indicated for acid-related gastrointestinal conditions, including gastroesophageal reflux disease, erosive esophagitis, gastric and duodenal peptic ulcer disease, Helicobacter pylori eradication regimens, and pathological hypersecretory states such as Zollinger-Ellison syndrome.